TABLE 1.

The demographic properties and clinical findings of the patients

Case	Age	Gender	BMI kg/m2	Symptoms	Days passed a	Total dose of favipiravir	Fluorescence on nails	Fluorescence on hair
1	27	Female	19.8	None	54	8000 mg	The middle portion of the nail plate and no fluorescence on the proximal and distal part of the nail plate.	Yes
2	42	Female	32.8	Loss of taste and smellHeadacheNausea vomitingDiarrhea	36	8000 mg	One half of the nail plate beginning from the proximal nail fold	Yes
3	51	Female	27.9	CoughBack painWeaknessLoss of taste and smell	30	8000 mg	One half of the nail plate beginning from the proximal nail fold	Yes
4	30	Female	26.6	Nausea vomitingHeadache	17	5600 mg b	The portion of the nail plate near to the proximal nail fold and lunula.	Yes
5	29	Male	34.7	None	17	None	No	No

^aDays passed after PCR positivity on Wood's examination day.

^bQuitted the drug because of nausea.